Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00330018
Recruitment Status : Completed
First Posted : May 25, 2006
Last Update Posted : April 21, 2015
Sponsor:
Information provided by:
Hadassah Medical Organization

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2010
Actual Study Completion Date : April 2010